Travel Time May Hamper Follow-Up Chemo.

‘While it is reassuring that most patients in this study received adjuvant chemotherapy on time, the known fact that patients traveling a lot more than 50 miles were less inclined to receive chemotherapy, regardless of insurance status, is concerning,’ said lead author Chun Chieh Lin, senior epidemiologist in the American Cancer Society, in a journal information release. ‘It tells us expanded insurance coverage, while important, may not fully address the barriers to sufferers receiving guideline-recommended treatment,’ Lin added..Pregnant women with epilepsy who were receiving monotherapy with carbamazepine, lamotrigine, phenytoin, or valproate were enrolled. Women taking other antiepileptic medicines were not included due to insufficient amounts of patients. Females receiving polytherapy weren’t included due to the association of polytherapy with poorer outcomes1 and the inability of the analysis to assess multiple feasible combinations of medications. A control band of nonexposed children had not been included, at the path of a National Institutes of Wellness review panel. Mothers with IQ ratings below 70 were excluded in order to avoid floor results and because maternal IQ is the main predictor of child IQ.9 Other exclusion criteria included positive serologic tests for syphilis or human immunodeficiency virus, progressive cerebral disease, other major disease , contact with teratogenic agents apart from antiepileptic medications, poor adherence to antiepileptic-drug use, drug abuse in the previous year, and drug-misuse sequelae.